About Contract Research and Manufacturing Services (CRAMs)

CRAMs Creating greater assets in the Pharma space.

Indian pharmaceutical industry is ranked 3rd by volume in addition, it is the largest supplier of generic drugs. Contract research and manufacturing services (CRAMs) are one of the booming sectors in the pharmaceutical and biotechnology industry. Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs) provide low-cost services in the pharmaceutical market.

What is CRAMs?

A CROs can provide services like preclinical research, clinical research, clinical trials management along with pharmacovigilance, and biopharmaceutical development.

A CMOs can provide manufacturing services. This can be divided into two main categories: primary manufacturing and secondary manufacturing. 

The pharmaceutical market uses outsourcing services from low-cost providers in the form of contract research organizations (CROs) and contract manufacturing organizations (CMOs). A large amount of investment followed by low productivity in R&Ds leads to cut manufacturing costs by outsourcing their research and manufacturing activities to low-cost countries like India.

India is one of the suggested destinations for outsourcing research as well as manufacturing activities. New age CRAMs suppliers are able to cater to not only pharmaceutical clients, but also biotech, agrochemicals, nutrition, animal health, consumer goods, and others. This has opened up wider growth opportunities for the sector. Currently, there is very less innovative manufacturing happening out in India as contract manufacturing. However, with the right scale, capacities, systems, and infrastructure, integrated service providers like Syngene are well placed to capture a larger share of the innovator manufacturing opportunities.

Why is CRAMs required?

China cannot satisfy all of the demands of the globe on its own due to the scale of outsourcing that is required. Highly qualified individuals with PhDs in chemistry or biology are required for contract research, and India excels in this area because it can consistently supply a highly skilled manpower pool at a far more cost-effective rate.

The outsourcing of contract research and manufacturing by international pharma companies to Indian businesses has significantly increased in order to reduce costs.

Asian economies or nations where cost structures have considerably decreased have a huge opportunity to gain from CRAMs, and Syngene, one of the top contract research organizations not just in Asia but also out of India, is in a prime position to do so.